Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
| Active as of 2026-06-04 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="condition-codes-cs"/>
<language value="en"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem condition-codes-cs</b></p><a name="condition-codes-cs"> </a><a name="hccondition-codes-cs"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">C50<a name="condition-codes-cs-C50"> </a></td><td>C50 — Malignant neoplasm of breast</td></tr><tr><td style="white-space:nowrap">C53<a name="condition-codes-cs-C53"> </a></td><td>C53 — Malignant neoplasm of cervix uteri</td></tr><tr><td style="white-space:nowrap">C54<a name="condition-codes-cs-C54"> </a></td><td>C54 — Malignant neoplasm of corpus uteri</td></tr><tr><td style="white-space:nowrap">C55<a name="condition-codes-cs-C55"> </a></td><td>C55 — Malignant neoplasm of uterus, part unspecified</td></tr><tr><td style="white-space:nowrap">C56<a name="condition-codes-cs-C56"> </a></td><td>C56 — Malignant neoplasm of ovary</td></tr><tr><td style="white-space:nowrap">C61<a name="condition-codes-cs-C61"> </a></td><td>C61 — Malignant neoplasm of prostate</td></tr><tr><td style="white-space:nowrap">C18<a name="condition-codes-cs-C18"> </a></td><td>C18 — Malignant neoplasm of colon</td></tr><tr><td style="white-space:nowrap">C19<a name="condition-codes-cs-C19"> </a></td><td>C19 — Malignant neoplasm of rectosigmoid junction</td></tr><tr><td style="white-space:nowrap">C20<a name="condition-codes-cs-C20"> </a></td><td>C20 — Malignant neoplasm of rectum</td></tr><tr><td style="white-space:nowrap">C15<a name="condition-codes-cs-C15"> </a></td><td>C15 — Malignant neoplasm of oesophagus</td></tr><tr><td style="white-space:nowrap">C16<a name="condition-codes-cs-C16"> </a></td><td>C16 — Malignant neoplasm of stomach</td></tr><tr><td style="white-space:nowrap">C22<a name="condition-codes-cs-C22"> </a></td><td>C22 — Malignant neoplasm of liver and intrahepatic bile ducts</td></tr><tr><td style="white-space:nowrap">C25<a name="condition-codes-cs-C25"> </a></td><td>C25 — Malignant neoplasm of pancreas</td></tr><tr><td style="white-space:nowrap">C34<a name="condition-codes-cs-C34"> </a></td><td>C34 — Malignant neoplasm of bronchus and lung</td></tr><tr><td style="white-space:nowrap">C32<a name="condition-codes-cs-C32"> </a></td><td>C32 — Malignant neoplasm of larynx</td></tr><tr><td style="white-space:nowrap">C11<a name="condition-codes-cs-C11"> </a></td><td>C11 — Malignant neoplasm of nasopharynx</td></tr><tr><td style="white-space:nowrap">C73<a name="condition-codes-cs-C73"> </a></td><td>C73 — Malignant neoplasm of thyroid gland</td></tr><tr><td style="white-space:nowrap">C64<a name="condition-codes-cs-C64"> </a></td><td>C64 — Malignant neoplasm of kidney, except renal pelvis</td></tr><tr><td style="white-space:nowrap">C67<a name="condition-codes-cs-C67"> </a></td><td>C67 — Malignant neoplasm of bladder</td></tr><tr><td style="white-space:nowrap">C43<a name="condition-codes-cs-C43"> </a></td><td>C43 — Malignant melanoma of skin</td></tr><tr><td style="white-space:nowrap">C71<a name="condition-codes-cs-C71"> </a></td><td>C71 — Malignant neoplasm of brain</td></tr><tr><td style="white-space:nowrap">C40<a name="condition-codes-cs-C40"> </a></td><td>C40 — Malignant neoplasm of bone and articular cartilage of limbs</td></tr><tr><td style="white-space:nowrap">C49<a name="condition-codes-cs-C49"> </a></td><td>C49 — Malignant neoplasm of connective and soft tissue</td></tr><tr><td style="white-space:nowrap">C81<a name="condition-codes-cs-C81"> </a></td><td>C81 — Hodgkin lymphoma</td></tr><tr><td style="white-space:nowrap">C83<a name="condition-codes-cs-C83"> </a></td><td>C83 — Non-follicular lymphoma (incl. Burkitt)</td></tr><tr><td style="white-space:nowrap">C85<a name="condition-codes-cs-C85"> </a></td><td>C85 — Other and unspecified types of non-Hodgkin lymphoma</td></tr><tr><td style="white-space:nowrap">C90<a name="condition-codes-cs-C90"> </a></td><td>C90 — Multiple myeloma and malignant plasma cell neoplasms</td></tr><tr><td style="white-space:nowrap">C91<a name="condition-codes-cs-C91"> </a></td><td>C91 — Lymphoid leukaemia</td></tr><tr><td style="white-space:nowrap">C92<a name="condition-codes-cs-C92"> </a></td><td>C92 — Myeloid leukaemia</td></tr><tr><td style="white-space:nowrap">C46<a name="condition-codes-cs-C46"> </a></td><td>C46 — Kaposi sarcoma</td></tr><tr><td style="white-space:nowrap">C69<a name="condition-codes-cs-C69"> </a></td><td>C69 — Malignant neoplasm of eye and adnexa (incl. retinoblastoma)</td></tr><tr><td style="white-space:nowrap">D05<a name="condition-codes-cs-D05"> </a></td><td>D05 — Carcinoma in situ of breast</td></tr><tr><td style="white-space:nowrap">D06<a name="condition-codes-cs-D06"> </a></td><td>D06 — Carcinoma in situ of cervix uteri</td></tr></table></div>
</text>
<url value="https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs"/>
<version value="0.1.0"/>
<name value="ConditionCodesCS"/>
<title value="Kenya Oncology Condition (ICD-10) Code System"/>
<status value="active"/>
<experimental value="false"/>
<date value="2026-06-04T14:49:30+00:00"/>
<publisher value="Digital Health Agency (DHA), Kenya"/>
<contact>
<name value="Digital Health Agency (DHA), Kenya"/>
<telecom>
<system value="url"/>
<value value="https://dha.go.ke"/>
</telecom>
<telecom>
<system value="email"/>
<value value="info@dha.go.ke"/>
</telecom>
</contact>
<contact>
<name value="Digital Health Agency Kenya – FHIR Team"/>
<telecom>
<system value="email"/>
<value value="info@dha.go.ke"/>
<use value="work"/>
</telecom>
<telecom>
<system value="url"/>
<value value="https://dha.go.ke"/>
<use value="work"/>
</telecom>
</contact>
<description
value="ICD-10 diagnosis codes for the most common malignancies in Kenya."/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="KE"/>
<display value="Kenya"/>
</coding>
</jurisdiction>
<caseSensitive value="true"/>
<content value="complete"/>
<count value="33"/>
<concept>
<code value="C50"/>
<display value="C50 — Malignant neoplasm of breast"/>
</concept>
<concept>
<code value="C53"/>
<display value="C53 — Malignant neoplasm of cervix uteri"/>
</concept>
<concept>
<code value="C54"/>
<display value="C54 — Malignant neoplasm of corpus uteri"/>
</concept>
<concept>
<code value="C55"/>
<display value="C55 — Malignant neoplasm of uterus, part unspecified"/>
</concept>
<concept>
<code value="C56"/>
<display value="C56 — Malignant neoplasm of ovary"/>
</concept>
<concept>
<code value="C61"/>
<display value="C61 — Malignant neoplasm of prostate"/>
</concept>
<concept>
<code value="C18"/>
<display value="C18 — Malignant neoplasm of colon"/>
</concept>
<concept>
<code value="C19"/>
<display value="C19 — Malignant neoplasm of rectosigmoid junction"/>
</concept>
<concept>
<code value="C20"/>
<display value="C20 — Malignant neoplasm of rectum"/>
</concept>
<concept>
<code value="C15"/>
<display value="C15 — Malignant neoplasm of oesophagus"/>
</concept>
<concept>
<code value="C16"/>
<display value="C16 — Malignant neoplasm of stomach"/>
</concept>
<concept>
<code value="C22"/>
<display
value="C22 — Malignant neoplasm of liver and intrahepatic bile ducts"/>
</concept>
<concept>
<code value="C25"/>
<display value="C25 — Malignant neoplasm of pancreas"/>
</concept>
<concept>
<code value="C34"/>
<display value="C34 — Malignant neoplasm of bronchus and lung"/>
</concept>
<concept>
<code value="C32"/>
<display value="C32 — Malignant neoplasm of larynx"/>
</concept>
<concept>
<code value="C11"/>
<display value="C11 — Malignant neoplasm of nasopharynx"/>
</concept>
<concept>
<code value="C73"/>
<display value="C73 — Malignant neoplasm of thyroid gland"/>
</concept>
<concept>
<code value="C64"/>
<display value="C64 — Malignant neoplasm of kidney, except renal pelvis"/>
</concept>
<concept>
<code value="C67"/>
<display value="C67 — Malignant neoplasm of bladder"/>
</concept>
<concept>
<code value="C43"/>
<display value="C43 — Malignant melanoma of skin"/>
</concept>
<concept>
<code value="C71"/>
<display value="C71 — Malignant neoplasm of brain"/>
</concept>
<concept>
<code value="C40"/>
<display
value="C40 — Malignant neoplasm of bone and articular cartilage of limbs"/>
</concept>
<concept>
<code value="C49"/>
<display value="C49 — Malignant neoplasm of connective and soft tissue"/>
</concept>
<concept>
<code value="C81"/>
<display value="C81 — Hodgkin lymphoma"/>
</concept>
<concept>
<code value="C83"/>
<display value="C83 — Non-follicular lymphoma (incl. Burkitt)"/>
</concept>
<concept>
<code value="C85"/>
<display
value="C85 — Other and unspecified types of non-Hodgkin lymphoma"/>
</concept>
<concept>
<code value="C90"/>
<display
value="C90 — Multiple myeloma and malignant plasma cell neoplasms"/>
</concept>
<concept>
<code value="C91"/>
<display value="C91 — Lymphoid leukaemia"/>
</concept>
<concept>
<code value="C92"/>
<display value="C92 — Myeloid leukaemia"/>
</concept>
<concept>
<code value="C46"/>
<display value="C46 — Kaposi sarcoma"/>
</concept>
<concept>
<code value="C69"/>
<display
value="C69 — Malignant neoplasm of eye and adnexa (incl. retinoblastoma)"/>
</concept>
<concept>
<code value="D05"/>
<display value="D05 — Carcinoma in situ of breast"/>
</concept>
<concept>
<code value="D06"/>
<display value="D06 — Carcinoma in situ of cervix uteri"/>
</concept>
</CodeSystem>